establishing a clinical genomics program at an academic medical center
DESCRIPTION
Establishing a Clinical Genomics Program at an Academic Medical Center. Jason Merker, M.D., Ph.D. Co-director, Stanford Clinical Genomics Service Regional APC/PDAS Meeting, Kauai 10/23/2014. Introduction to Clinical Genomics ( in 5 Slides). Wellcome Collection – Medicine Now. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/1.jpg)
Establishing a Clinical Genomics Program at an Academic Medical Center
Jason Merker, M.D., Ph.D.Co-director, Stanford Clinical Genomics Service
Regional APC/PDAS Meeting, Kauai10/23/2014
![Page 2: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/2.jpg)
Introduction to Clinical Genomics(in 5 Slides)
![Page 3: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/3.jpg)
Wellcome Collection – Medicine Now
3.4 billion units of DNA code:• 127 volumes• 1,000 pages per volume
![Page 4: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/4.jpg)
Size of targeted regions in assays
Genome – 127 volumes
Exome – 2.5 volumes
500 gene panel – 40 pages
50 gene panel – 4 pages
Single gene – <1/10 of a page
![Page 5: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/5.jpg)
Tumor/Normal or Trio Genome Sequencing Data
![Page 6: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/6.jpg)
Limit of detection - % allele burden
Assay typeAverage limit of detection (% allele burden)
Genome sequencing ~20 – 30%Exome sequencing ~20 – 30%NGS-based gene panels 5 – 10%Sanger sequencing 20%Single mutation assay <10%
![Page 7: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/7.jpg)
Some mutation types are difficult to detect by genome or exome sequencing technologies
Mutation type Difficulty
Single nucleotide variant
Small indels (<10-20 bp)
Copy-number variants
Structural variants
Larger indels
![Page 8: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/8.jpg)
Introduction to Clinical Genomicsat Stanford
![Page 9: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/9.jpg)
Clinical Genomics Efforts at Stanford
Clinical GenomicsService
GenePool Biobank
Basic, Translational,and Clinical Research
![Page 10: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/10.jpg)
Advisory Committee for Clinical GenomicsName Organization/Department Director’s Role
C. Dawes Stanford Children’s Health CEO
L. Minor School of Medicine Dean
A. Rubin Stanford Health Care President and CEO
T. Quertermous* CV Med GenePool Biobank
J. Ford* Oncology Cancer Institute Genomics ProgramsChief Cancer Genetics
E. Ashley CV Med Co-director Clinical Genomics ServiceInstitute for Inherited CV Disease
L. Boxer Hematology Vice Dean
A. Butte Pediatrics Chief Division of Systems Medicine
M. Cho Pediatrics Center for Biomedical Ethics
L. Hudgins Pediatrics Chief Medical Genetics
J. Merker Pathology Co-director Clinical Genomics Service
K. Ormond Genetics Genetics and Genomics Counseling Program
I. Schrijver Pathology Molecular Pathology Laboratory
M. Snyder Genetics Chair GeneticsDirector Center for Genomics & PM
![Page 11: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/11.jpg)
Stanford Clinical Genomics Service
• Directors – Jason Merker (Path), Euan Ashley (CV Med)• Department – Pathology• Goal – Build a clinical laboratory service at Stanford University
Medical Center that uses genome sequencing to evaluate adult and pediatric patients with unexplained genetic diseases.
• Pilot – Develop analysis/curation pipeline and perform genome sequencing on 4 patient populations (100 cases total):– Heritable cancer predisposition– Heritable cardiovascular disorders– Pediatric syndromes – Familial adverse drug reactions or sensitivity
![Page 12: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/12.jpg)
Workflow – 1
Test Request Patient and physicianrequest genome sequencingfor heritable disease throughEMR
Review by GeneticTest Consultation Service• Genetic Counselor• Molecular Pathologist• Medical Geneticist
Analysis TeamMP/MG
Biocurator
Genetic Counselor
Treating Team
Outside Faculty
Expert (prn)
Establish questions being posed bypatient and treating team• Genetic?• Candidate variants and analysis
approach• Clinical use
![Page 13: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/13.jpg)
Workflow – 2
Insuranceauthorization
Patient meets with geneticcounselor• Clinical counseling & consent• *Options for return of
secondary findings• 2-step consent process for
non-actionable findings• Biobanking and data-sharing
counseling & consent
Blood draw• 1 tube for genome
sequencing• 1 tube for confirmatory
studies and specimen ID• 1 tube for biobanking
(with appropriate consent)
![Page 14: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/14.jpg)
Workflow – 3
Illumina genome sequencing
Data analysis (open source, commercial, and Stanford developed):• Alignment• Variant calling• Quality management• ID and gender checks to
confirm specimen identity
Variant filtering/prioritization• Phenotype• Inheritance pattern• Predicted deleterious• Secondary findings
![Page 15: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/15.jpg)
Workflow – 4
Variant verification by orthogonal method• Segregation analysis
Curation meeting anddraft report
Gen
omic
s Re
view
Boa
rds
Pediatrics
Cardiovascular
Oncology
Pharmacogenomics
Genomics Review Groups• Genomics Service• Treating Team• Content expert
![Page 16: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/16.jpg)
Workflow – 5
Final report generated and uploaded to EMR
Patient meets with genetic counselor and relevant members of treatment team
Yearly re-analysis upon request• Improved analysis• Improved sequencing• Increased medical
knowledge
![Page 17: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/17.jpg)
Case 1 – 30 YOM w/ DCM
• TTN A-band truncating variant that segregates with disease in large family – likely pathogenic
• RYR1 variant (malignant hyperthermia) – likely pathogenic vs. variant of uncertain significance
![Page 18: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/18.jpg)
Case 2
![Page 19: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/19.jpg)
Clinical Genetic Test Consultation Service
![Page 20: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/20.jpg)
Clinical Genetic Test Consultation ServiceRationale #1 – The number of clinical genetic tests is
becoming unmanageable
The CDC estimates that genetic tests for use in the clinical setting have been developed for approximately 2,000 diseases
![Page 21: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/21.jpg)
Clinical Genetic Test Consultation ServiceRationale #2 – The number of misorders for complex
genetic testing is high
Miller CE et al. 2014. Am J Med Genet Part A 164A:1094–1101.
“Approximately 25% of all requests for complex genetic tests assessing germ line mutations were changed following review.”
![Page 22: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/22.jpg)
Clinical Genetic Test Consultation Service – Summary of rationales
• The number, indications, and complexity of genetic tests offered have been increasing, and will continue to do so for the foreseeable future.
• It is therefore not surprising that mistakes often occur in the ordering of complex genetic tests.
• Incorrect ordering of genetic tests results in unnecessary costs to the healthcare system, but more importantly adversely affects the care of our patients– Failure or delays in getting the needed test results– Communication of results from the incorrect test– Providing genetic information that was neither requested nor
desired by the patient
![Page 23: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/23.jpg)
Clinical Genetic Test Consultation Service – Personnel
MolecularPathologist
GeneticCounselor
MedicalGeneticist
![Page 24: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/24.jpg)
Clinical Genetic Test Consultation Service
1. Provide consultation to SUMC healthcare providers needing further information on available genetic testing.
2. Review all quests for send-out genetic testing from Stanford Clinical Laboratories to identify and help correct genetic test misorders.
3. Work with Genetic Test Utilization Committee develop innovative, provider-friendly ways to educate our physicians about genetic test utilization (e.g., pop-up windows in EMR offering test consultation or other educational information).
4. Assist departments and divisions with educational activities related to genetic test utilization (e.g., seminars, presentation to new residents) and with establishing protocols for genetic test ordering for common use cases
![Page 25: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/25.jpg)
Clinical genomics educational efforts
![Page 26: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/26.jpg)
Open Didactic Core Curriculum in Genomic Medicine
1. Experimental methods for measuring and manipulating DNA/RNA2. Fundamentals of human genetic variation3. Microarrays and analysis of hybridization data4. Sequencing methods5. Heritable genetic disorders6. Acquired mutations in human cancers I: solid tumors7. Acquired mutations in human cancers II: hematopoietic
malignancies8. Pharmacogenomics9. HLA genetics10. Ethical, legal, and economic implications of clinical genomic
testing
Schrijver I et al. J Mol Diagn. 2013;15:141.
![Page 27: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/27.jpg)
Elective Course in Advanced Genomic Medicine
1. Next-generation sequencing methods 2.02. Human genetic variation 2.03. DNA sequence analysis methods I: sequence
databases and files4. DNA sequence analysis methods II: sequence
alignment algorithms5. DNA sequence analysis methods III: genome assembly
and analysis6. Introduction to scripting programming languages7. Statistical tools for sequence analysis and genomics
Schrijver I et al. J Mol Diagn. 2013;15:141.
![Page 28: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/28.jpg)
Elective Course in Advanced Genomic Medicine
1. Next-generation sequencing methods 2.02. Human genetic variation 2.03. DNA sequence analysis methods I: sequence
databases and files4. DNA sequence analysis methods II: sequence
alignment algorithms5. DNA sequence analysis methods III: genome assembly
and analysis6. Introduction to scripting programming languages7. Statistical tools for sequence analysis and genomics
Schrijver I et al. J Mol Diagn. 2013;15:141.
![Page 29: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/29.jpg)
New Elective Course in Advanced Genomic Medicine
• Genome and exome analysis for heritable disease
• Tumor/normal sequencing analysis
• RNA sequencing analysis
• Unix commands and basic scripting
![Page 30: Establishing a Clinical Genomics Program at an Academic Medical Center](https://reader035.vdocument.in/reader035/viewer/2022062422/568132a8550346895d994cfa/html5/thumbnails/30.jpg)
End